Tele: 561.316.3330
Breaking Medical Device News

Wednesday, September 22, 2021

HomeEXECUTIVESCharles F. D'Agostino Appointed to RedHawk BOD

Charles F. D’Agostino Appointed to RedHawk BOD

Mr. D’Agostino is the retired founder and Executive Director of the LSU Innovation Park and the Louisiana Business & Technology Center (“LBTC”) at Louisiana State University and has been actively involved in entrepreneurship, economic development, and technology transfer for the last 30 years. While overseeing the LBTC, Mr. D’Agostino directed the five LSU Business Incubators, LSU rural and disaster business counseling programs, and the Louisiana Technology Transfer Office.

Mr. D’Agostino currently serves as vice-chairman of the Board of Trustees of the Baton Rouge General Hospital. Previously, he served on the Board of Directors of the Association of University Research Parks (1999-2005 and 2011-17) and was President from 2015 to 2017. He also served on the board of the National Business Incubation Association from 1991 to 1998. Mr. D’Agostino was given the Lifetime Achievement Award by the National Business Incubation Association in 2011 and the AURP Career Achievement Award in 2018. His awards and accomplishments also include:

  • 2018 Career Achievement Award – Association of University Research Parks;
  • International Economic Development Council’s Higher Education Committee (2010-2012);
  • 2010 Fulbright Specialist in Economic Development;
  • Commissioner of the Greater Baton Rouge Port Commission (1996-2005); and
  • Small Business Administration – Advocate of the Year in Louisiana (1992).

Mr. D’Agostino received a Bachelor of Science for Arts & Science degree from Louisiana State University with a concentration in Chemistry. In 1972, Mr. D’Agostino also received a Masters of Business Administration degree from Louisiana State University.

“We are pleased to welcome Charlie as a new independent director to our board. He is joining RedHawk at an exciting time,” said G. Darcy Klug, RedHawk’s Chairman and Interim Chief Executive Officer. “We’ve worked with Charlie and his team at the LSU Innovation Center from the outset – starting with the engineering redesign of the SANDD™ line of products and continuing with the installation and initial testing of the Centri Controlled Entry System.  Charlie is well respected in both technology and economic enterprise development and will be a tremendous asset to our business development as we continue to execute our business plan.”

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Kleiner Device Labs Receives FDA Market Clearance for KG2 Surge Flow-Thru Interbody System

The system maximizes total bone graft delivery volume, better distributes graft bilaterally into the intervertebral disc space, and streamlines the implant delivery, positioning, and grafting process for TLIF and PLIF spinal fusion procedures.

Matthew Cranfill New ExtriCARE USA Director Of Clinical Services

"Matt's impressive experience and skillset easily made him our top pick," said Peter Mason, President of ExtriCARE USA.

Shannon Lantzy MedCrypt New VP of Consulting

"I met Shannon at a healthcare-related event several years ago and was immediately impressed with her passion and drive to move healthcare into a digital future," said Mike Kijewski, CEO of MedCrypt.

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

By using this website you agree to accept Medical Device News Magazine Privacy Policy